Affording Medication: Focus on Biosimilars
Learn how to make IBD treatment more affordable in this webinar focused on biosimilars for Crohn’s disease and ulcerative colitis. Explore what biosimilars are, how they compare to biologic medications, insurance coverage and medication costs, patient assistance programs, and tips for navigating treatment access. This educational session is designed to help people living with inflammatory bowel disease (IBD) make informed decisions about their care and advocate for affordable treatment options.
Video Length00:23:18
Navigating Insurance as a Crohn's or Colitis Patient: What is a Biosimilar?
Navigating insurance can feel like jumping through hoops if you live with Crohn's disease or ulcerative colitis. In this session about navigating insurance, Lindsay Trocke, PharmD, BCACP, discusses the nuance of insurance for inflammatory bowel disease (IBD) patients, and explains the role of biosimilars in navigating insurance.
Video Length00:24:05
Navigating Insurance Challenges in IBD
Shuba Bhat, an IBD clinical pharmacist from Cleveland Clinic, shares tips for navigating insurance challenges.
Video Length01:05:51
Navigating the Costs of IBD
Learn about issues related to insurance coverage for IBD medications including co-pay accumulators, step therapy, and surprise billing, identify strategies to appeal a denied claim and how to work with your provider on appeals.